Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells

References

• Horwitz EM, Le BK, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, . Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy. 2005;7:393–5.
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–7.
   PubMed Web of Science ®Google Scholar
• Wagner W, Ho AD. Mesenchymal stem cell preparations: comparing apples and oranges. Stem Cell Rev. 2007;3: 239–48.
   PubMed Web of Science ®Google Scholar
• Ho AD, Wagner W, Franke W. Heterogeneity of mesenchymal stromal cell preparations. Cytotherapy. 2008;10:320–30.
   PubMed Web of Science ®Google Scholar
• Satija NK, Singh VK, Verma YK, Gupta P, Sharma S, Afrin F, . Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine. J Cell Mol Med. 2010;13:4385–4402.
   Google Scholar
• Sensebe L, Krampera M, Schrezenmeier H, Bourin P, Giordano R. Mesenchymal stem cells for clinical application. Vox Sang. 2010;98:93–107.
   PubMed Web of Science ®Google Scholar
• Nesselmann C, Ma N, Bieback K, Wagner W, Ho A, Konttinen YT, . Mesenchymal stem cells and cardiac repair. J Cell Mol Med. 2008;12:1795–810.
   PubMed Web of Science ®Google Scholar
• Heiskanen A, Satomaa T, Tiitinen S, Laitinen A, Mannelin S, Impola U, . N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells. 2007;25:197–202.
   PubMed Web of Science ®Google Scholar
• Sundin M, Ringden O, Sundberg B, Nava S, Gotherstrom C, Le BK. No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica. 2007;92:1208–15.
   PubMed Web of Science ®Google Scholar
• Halme DG, Kessler DA. FDA regulation of stem-cell-based therapies. N Engl J Med. 2006;355:1730–5.
   PubMed Web of Science ®Google Scholar
• Stute N, Holtz K, Bubenheim M, Lange C, Blake F, Zander AR. Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Exp Hematol. 2004;32:1212–25.
   PubMed Web of Science ®Google Scholar
• Koller MR, Maher RJ, Manchel I, Oxender M, Smith AK. Alternatives to animal sera for human bone marrow cell expansion: human serum and serum-free media. J Hematother. 1998;7:413–23.
   PubMedGoogle Scholar
• Kuznetsov SA, Mankani MH, Robey PG. Effect of serum on human bone marrow stromal cells: ex vivo expansion and in vivo bone formation. Transplantation. 2000;70:1780–7.
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Hirayama F, Wakamoto S, Fujihara M, Murahashi H, Sato N, . Bone marrow stromal cells prepared using AB serum and bFGF for hematopoietic stem cells expansion. Transfusion. 2002;42:921–7.
   PubMedGoogle Scholar
• Perez-Ilzarbe M, Díez-Campelo M, Aranda P, Tabera S, Lopez T, del Cañizo C, . Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy. Transfusion. 2009;49:1901–10.
   PubMed Web of Science ®Google Scholar
• Bieback K, Hecker A, Kocaomer A, Lannert H, Schallmoser K, Strunk D, . Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells. 2009;27:2331–41.
   PubMed Web of Science ®Google Scholar
• Muller I, Kordowich S, Holzwarth C, Spano C, Isensee G, Staiber A, . Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy. 2006;8:437–44.
   PubMed Web of Science ®Google Scholar
• Ng F, Boucher S, Koh S, Sastry KS, Chase L, Lakshmipathy U, . PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood. 2008;112:295–307.
   PubMed Web of Science ®Google Scholar
• Kocaoemer A, Kern S, Kluter H, Bieback K. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells. 2007; 25:1270–8.
   PubMed Web of Science ®Google Scholar
• Schallmoser K, Bartmann C, Rohde E, Reinisch A, Kashofer K, Stadelmeyer E, . Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion. 2007;47:1436–46.
   PubMed Web of Science ®Google Scholar
• Schallmoser K, Rohde E, Reinisch A, Bartmann C, Thaler D, Drexler C, . Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Eng Part C Methods. 2008; 14:185–96.
   PubMed Web of Science ®Google Scholar
• Carrancio S, Lopez-Holgado N, Sanchez-Guijo FM, Villaron E, Barbado V, Tabera S, . Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Exp Hematol. 2008;36:1014–21.
   PubMed Web of Science ®Google Scholar
• Avanzini MA, Bernardo ME, Cometa AM, Perotti C, Zaffaroni N, Novara F, . Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors. Haematologica. 2009;94:1649–60.
   PubMed Web of Science ®Google Scholar
• Capelli C, Domenghini M, Borleri G, Bellavita P, Poma R, Carobbio A, . Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts. Bone Marrow Transplant. 2007;40:785–91.
   PubMed Web of Science ®Google Scholar
• Blande IS, Bassaneze V, Lavini-Ramos C, Fae KC, Kalil J, Miyakawa AA, . Adipose tissue mesenchymal stem cell expansion in animal serum-free medium supplemented with autologous human platelet lysate. Transfusion. 2009; 49:2680–5.
   PubMed Web of Science ®Google Scholar
• Doucet C, Ernou I, Zhang Y, Llense JR, Begot L, Holy X, . Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol. 2005;205:228–36.
   PubMed Web of Science ®Google Scholar
• Horn P, Bork S, Diehlmann A, Walenda T, Eckstein V, Ho AD, . Isolation of human mesenchymal stromal cells is more efficient by red blood cell lysis. Cytotherapy. 2008;10:676–85.
   PubMed Web of Science ®Google Scholar
• Horn P, Bork S, Wagner W. Standardized isolation of human mesenchymal stromal cells with red blood cell lysis. Methods Mol Biol. 2010; in press.
   Google Scholar
• Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood. 2001;98:2615–25.
   PubMed Web of Science ®Google Scholar
• Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U, . Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol. 2005;33:1402–16.
   PubMed Web of Science ®Google Scholar
• Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, Saffrich R, . Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS ONE. 2008; 5:e2213.
   Google Scholar
• Cristofalo VJ, Allen RG, Pignolo RJ, Martin BG, Beck JC. Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation. Proc Natl Acad Sci USA. 1998;95:10614–9.
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, . Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–7.
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63.
   PubMed Web of Science ®Google Scholar
• Pavlidis P, Noble WS. Analysis of strain and regional variation in gene expression in mouse brain. Genome Biol. 2001; 2:e42.
   Google Scholar
• Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, . A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA. 1995;92:9363–7.
   PubMed Web of Science ®Google Scholar
• Chevallier N, Anagnostou F, Zilber S, Bodivit G, Maurin S, Barrault A, . Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate. Biomaterials. 2010;31: 270–8.
   PubMed Web of Science ®Google Scholar
• Owen M. Marrow stromal stem cells. J Cell Sci. 1988; 10(suppl):63–76.
   Google Scholar
• Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci. 2000;113:1161–6.
   PubMed Web of Science ®Google Scholar
• Bieback K, Kern S, Kluter H, Eichler H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells. 2004;22:625–34.
   PubMed Web of Science ®Google Scholar
• Wagner W, Feldmann RE Jr, Seckinger A, Maurer MH, Wein F, Blake J, . The heterogeneity of human mesenchymal stem cell preparations: evidence from simultaneous analysis of proteomes and transcriptomes. Exp Hematol. 2006;34: 536–48.
   PubMed Web of Science ®Google Scholar
• Harrison P, Cramer EM. Platelet alpha-granules. Blood Rev. 1993;7:52–62.
   PubMed Web of Science ®Google Scholar
• Coppinger JA, Cagney G, Toomey S, Kislinger T, Belton O, McRedmond JP, . Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood. 2004;103:2096–104.
   PubMed Web of Science ®Google Scholar
• Wagner W, Roderburg C, Wein F, Diehlmann A, Frankhauser M, Schubert R, . Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors. Stem Cells. 2007;10: 2638–57.
   Google Scholar
• Gregory CA, Singh H, Perry AS, Prockop DJ. The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J Biol Chem. 2003;278:28067–78.
   PubMed Web of Science ®Google Scholar
• Bork S, Pfister S, Witt H, Horn P, Korn B, Ho AD, . DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell. 2010; 9:54–63.
   PubMed Web of Science ®Google Scholar
• Schallmoser K, Bartmann C, Rohde E, Bork S, Guelly C, Obenauf AC, . Replicative senescence-associated gene expression changes in mesenchymal stromal cells are similar under different culture conditions. Haematologica. 2010;95:867–874.
   PubMed Web of Science ®Google Scholar
• Bonin M, Stolzel F, Goedecke A, Richter K, Wuschek N, Holig K, . Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant. 2009;43:245–51.
   PubMedGoogle Scholar